Ivermectin + Praziquantel + Pyrantel Pamoate

Verify with FDA CVM →

1,303 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
1,303
Total Reports
12
Deaths Reported
90.0%
Death Rate

Active Ingredients

IvermectinPraziquantelPyrantel Pamoate

Administration Routes

OralUnknownIntra-Arterial

Species Affected

Dog 1,146
Unknown 155
Cat 2

Most Affected Breeds

Unknown 158
Retriever - Labrador 156
Shepherd Dog - German 82
Dog (unknown) 80
Pit Bull 66
Retriever - Golden 56
Chihuahua 50
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 36
Terrier - Yorkshire 32
Crossbred Canine/dog 27

Most Reported Reactions

Vomiting 394
Lack of efficacy (endoparasite) - heartworm 393
Diarrhoea 118
Lethargy (see also Central nervous system depression in 'Neurological') 74
Tablets, Abnormal 71
INEFFECTIVE, HOOKS 65
Appearance, Abnormal 63
Containers, Damaged 58
Lack of efficacy (endoparasite) - hookworm 52
Overdose 36
Lack of efficacy (endoparasite) - roundworm NOS 32
Not eating 31

Outcome Breakdown

Outcome Unknown
654 (57.0%)
Recovered/Normal
458 (39.9%)
Ongoing
24 (2.1%)
Died
6 (0.5%)
Euthanized
6 (0.5%)

Data Summary

Metric Value
Total adverse event reports 1,303
Reports involving death 12
Case-fatality rate (reported events) 90.0%
Distinct species in reports 3
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 3

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ivermectin + Praziquantel + Pyrantel Pamoate Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 1,303 adverse event reports referencing Ivermectin + Praziquantel + Pyrantel Pamoate, including 12 reports in which the animal died — a 90.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredients on file: Ivermectin, Praziquantel, Pyrantel Pamoate. Reported administration routes include Oral, Unknown, Intra-Arterial. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ivermectin + Praziquantel + Pyrantel Pamoate reports are Dog (1,146 reports), Unknown (155 reports), Cat (2 reports), with Dog accounting for the largest share. Within those species, Unknown (158), Retriever - Labrador (156), Shepherd Dog - German (82) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ivermectin + Praziquantel + Pyrantel Pamoate are Vomiting (394), Lack of efficacy (endoparasite) - heartworm (393), Diarrhoea (118), Lethargy (see also Central nervous system depression in 'Neurological') (74). Of the 1,148 reports with a coded outcome, Outcome Unknown is the leading category at 57.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ivermectin + Praziquantel + Pyrantel Pamoate.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial